Coeptis Therapeutics Inc. Annual Cost of Revenue in USD from 2020 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Coeptis Therapeutics Inc. quarterly/annual Cost of Revenue history and growth rate from 2020 to 2021.
  • Coeptis Therapeutics Inc. Cost of Revenue for the quarter ending September 30, 2022 was $0.000.
  • Coeptis Therapeutics Inc. Cost of Revenue for the twelve months ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Cost of Revenue for 2021 was $0.000, a 100% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $0 -$964K -100% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-11
2020 $964K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.